Interpace Biosciences logo
Interpace Biosciences IDXG
$ 2.68 0.0%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Interpace Biosciences Balance Sheet 2011-2024 | IDXG

Annual Balance Sheet Interpace Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-1.65 M -2.4 M -1.39 M 1.97 M 4.78 M -6.07 M -15.2 M 7.31 M 87 K 4.15 M -45.6 M -52.8 M -64.3 M

Long Term Debt

1.47 M 1.85 M 520 K - 3 M - - 7.91 M 7.23 M 27.2 M - - -

Long Term Debt Current

377 K 578 K 762 K 1.03 M - - - - 1.16 M - - - -

Total Non Current Liabilities

- - - 10 M 38.7 M 7.01 M 5.64 M 19 M 31.3 M 62.2 M 5.18 M 6.43 M 7.78 M

Total Current Liabilities

17.5 M 14.3 M 15.7 M 18.2 M 17.3 M 8.49 M 8.09 M 16.2 M 23.4 M 33.6 M 31.4 M 36.4 M 46.1 M

Total Liabilities

28.2 M 32.5 M 34.3 M 28.2 M 56 M 15.5 M 13.7 M 35.2 M 54.7 M 95.8 M 36.6 M 42.8 M 53.9 M

Deferred Revenue

- - - 54 K 457 K - - - - 6.75 M 9.38 M 14.5 M 15.9 M

Retained Earnings

-248 M -249 M -227 M -212 M -168 M -141 M -132 M -120 M -111 M -99.9 M -83.8 M -79.3 M -53.7 M

Total Assets

13 M 16 M 38.4 M 45.7 M 69.1 M 48.4 M 53.6 M 41.8 M 67.7 M 116 M 69.1 M 78.4 M 113 M

Cash and Cash Equivalents

3.5 M 4.83 M 2.67 M 2.77 M 2.32 M 6.07 M 15.2 M 602 K 8.31 M 23.1 M 45.6 M 52.8 M 64.3 M

Book Value

-15.1 M -16.5 M 4.12 M 17.5 M 13 M 32.9 M 39.9 M 6.53 M 13 M 20.1 M 32.5 M 35.6 M 59.5 M

Total Shareholders Equity

-61.7 M -63.1 M -42.4 M -29.1 M -4.48 M 15.4 M 39.9 M 39.9 M 13 M 20.1 M 32.5 M 35.6 M 59.5 M

All numbers in USD currency

Quarterly Balance Sheet Interpace Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.19 M 1.29 M 1.36 M 1.47 M 1.56 M 1.65 M 1.75 M 1.85 M 184 K 2.72 M 2.97 M 520 K 3.23 M 3.2 M 3.44 M 3.68 M 3.78 M 3.68 M 1.47 M 2.71 M 2.96 M 2.59 M 2.59 M - - - - - - - 4.36 M 7.91 M 7.91 M 7.91 M 7.91 M 7.23 M 7.23 M 7.23 M 7.23 M 27.2 M 27.2 M 27.2 M 27.2 M - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - 4.56 M 4.57 M - - 4.25 M 4.32 M 4.73 M 4.34 M 4.32 M 4.29 M 4.29 M 4.29 M 4.29 M - - 4.71 M 4.7 M 6.18 M 8.08 M 8.74 M 6.18 M 8.81 M 9.14 M 9.14 M 9.14 M 5.18 M 5.18 M 5.18 M 5.18 M 6.43 M 6.43 M 6.43 M 6.43 M 7.78 M 7.78 M 7.78 M 7.78 M

Total Liabilities

25.2 M 25.5 M 26.7 M 28.2 M 30.4 M 31.6 M 31.9 M 32.5 M 30.4 M 36.9 M 36.2 M 34.3 M 32.4 M 32.4 M 30.2 M 28.2 M 28.2 M 28.2 M 28.2 M 29.8 M 29.8 M 29.8 M 29.8 M 15.7 M 15.5 M 15.5 M 15.5 M 13.7 M 13.7 M 13.7 M 13.7 M 35.2 M 35.2 M 35.2 M 35.2 M 54.7 M 54.7 M 54.7 M 54.7 M 95.8 M 95.8 M 95.8 M 95.8 M 36.6 M 36.6 M 36.6 M 36.6 M 42.8 M 42.8 M 42.8 M 42.8 M 53.9 M 53.9 M 53.9 M 53.9 M

Deferred Revenue

- - - - - - - - - 18 K 31 K 40 K 40 K 43 K 52 K 54 K 54 K 54 K 54 K 457 K 457 K 457 K 457 K - - - - - - - - - - - - - 5.11 M 6.87 M 10.9 M 6.75 M 7.61 M 6.75 M 6.75 M 7.35 M 9.38 M 9.38 M 9.38 M 14.5 M 14.5 M 14.5 M 14.5 M 15.9 M 15.9 M 15.9 M 15.9 M

Retained Earnings

-244 M -246 M -248 M -248 M -249 M -248 M -249 M -249 M -247 M -233 M -229 M -227 M -223 M -220 M -216 M -212 M -212 M -212 M -212 M -186 M -186 M -186 M -186 M -159 M -141 M -141 M -141 M -132 M -132 M -132 M -132 M -120 M -120 M -120 M -120 M -111 M -111 M -111 M -111 M -99.9 M -99.9 M -99.9 M -99.9 M -83.8 M -83.8 M -83.8 M -83.8 M -79.3 M -79.3 M -79.3 M -79.3 M -53.7 M -53.7 M -53.7 M -53.7 M

Total Assets

14 M 13 M 12.1 M 13 M 14.2 M 15.9 M 15.9 M 16 M 15.3 M 35.5 M 38.4 M 38.4 M 40.3 M 43.2 M 43.9 M 45.7 M 45.7 M 45.7 M 45.7 M 51.5 M 51.5 M 51.5 M 51.5 M 31.1 M 48.4 M 48.4 M 48.4 M 36.6 M 53.6 M 53.6 M 53.6 M 25.1 M 41.8 M 41.8 M 41.8 M 64.7 M 67.7 M 67.7 M 67.7 M 115 M 116 M 116 M 116 M 69.1 M 69.1 M 69.1 M 69.1 M 78.4 M 78.4 M 78.4 M 78.4 M 113 M 113 M 113 M 113 M

Cash and Cash Equivalents

2.11 M 2.02 M 2.81 M 3.5 M 5.03 M 5.08 M 5.6 M 4.83 M 6.31 M 2.12 M 3.1 M 2.67 M 3.43 M 3.79 M 2.84 M 2.77 M 2.77 M 2.77 M 2.77 M 2.32 M 2.32 M 2.32 M 2.32 M 6.07 M 6.07 M 6.07 M 6.07 M 15.2 M 15.2 M 15.2 M 15.2 M 602 K 602 K 602 K 602 K 8.31 M 8.31 M 8.31 M 8.31 M 23.1 M 23.1 M 23.1 M 23.1 M 45.6 M 45.6 M 45.6 M 45.6 M 52.8 M 52.8 M 52.8 M 52.8 M 64.3 M 64.3 M 64.3 M 64.3 M

Book Value

-11.1 M -12.5 M -14.6 M -15.1 M -16.1 M -15.7 M -16 M -16.5 M -15.1 M -1.42 M 2.2 M 4.12 M 7.89 M 10.7 M 13.6 M 17.5 M 17.5 M 17.5 M 17.5 M 21.7 M 21.7 M 21.7 M 21.7 M 15.4 M 32.9 M 32.9 M 32.9 M 22.9 M 39.9 M 39.9 M 39.9 M -10.1 M 6.53 M 6.53 M 6.53 M 10.1 M 13 M 13 M 13 M 19.4 M 20.1 M 20.1 M 20.1 M 32.5 M 32.5 M 32.5 M 32.5 M 35.6 M 35.6 M 35.6 M 35.6 M 59.5 M 59.5 M 59.5 M 59.5 M

Total Shareholders Equity

-57.7 M -59 M -61.1 M -61.7 M -62.7 M -62.2 M -62.5 M -63.1 M -61.6 M -48 M -44.3 M -42.4 M -38.6 M -35.8 M -32.9 M -29.1 M -29.1 M -29.1 M -29.1 M -4.48 M -4.48 M -4.48 M -4.48 M 15.4 M 32.9 M 32.9 M 32.9 M 22.9 M 39.9 M 39.9 M 39.9 M -10.1 M 6.53 M 6.53 M 6.53 M 10.1 M 13 M 13 M 13 M 19.4 M 20.1 M 20.1 M 20.1 M 32.5 M 32.5 M 32.5 M 32.5 M 35.6 M 35.6 M 35.6 M 35.6 M 59.5 M 59.5 M 59.5 M 59.5 M

All numbers in USD currency